Jubilant Cadista Pharmaceuticals

Jubilant Cadista Pharmaceuticals (United States) has no DMF, CEP or site registration linked in our records. 48 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Jubilant Cadista Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/jubilant-cadista-pharmaceuticals

Overview

Jubilant Cadista Pharmaceuticals is a pharmaceutical company headquartered in Salisbury, United States.

FDA compliance signals

48 FDA enforcement records linked to this company.

  • 4832025-01-15

    Rejected in-process materials not quarantined

  • 4832025-01-15

    Records not made readily available to FDA

  • 4832025-01-15

    Signature and checking of records -- 2 persons

  • 4832025-01-15

    Systems in place to comply with verification requirements

  • 4832025-01-15

    Identification of Persons Performing Significant Steps

  • recall — Class III2023-01-11

    Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.

  • recall — Class II2022-08-03

    Failed dissolution specifications.

  • recall — Class II2022-08-03

    Failed Dissolution Specifications

  • recall — Class III2022-04-13

    Subpotent

  • recall — Class I2022-04-06

    Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride

  • recall — Class III2021-09-08

    Subpotent

  • recall — Class II2021-04-21

    Failed Dissolution Specifications

  • recall — Class III2021-03-10

    Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

  • recall — Class II2020-12-02

    Failed Tablet/Capsule Specification

  • recall — Class III2020-11-11

    Subpotent

  • recall — Class III2020-06-03

    Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.

  • recall — Class II2020-03-25

    CGMP Deviations: Presence of dark brown discoloration on edges of tablets

  • 4832020-02-28

    Procedures for non-sterile drug products

  • 4832020-02-28

    Procedures to be written and followed

  • recall — Class II2019-12-18

    Presence of Foreign Substance: Presence of a foreign object in a single tablet.

  • recall — Class II2019-10-23

    CGMP Deviation: Presence of dark brown discoloration on edges of tablets.

  • recall — Class I2019-08-07

    Failed dissolution specifications : failed results at the 3-month stability time point.

  • recall — Class II2019-04-10

    Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.

  • recall — Class III2019-03-13

    Failed Dissolution Specifications; 9-monthstability timepoint

  • recall — Class II2018-10-17

    Discoloration: Presence of dark discoloration or brown spots on the edges of the tablets.

  • recall — Class III2018-09-26

    Failed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay.

  • recall — Class III2018-08-29

    Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

  • recall — Class III2018-08-29

    Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

  • recall — Class III2018-08-29

    Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

  • recall — Class III2018-08-29

    Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

  • recall — Class III2018-06-13

    Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).

  • recall — Class III2017-11-22

    Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.

  • recall — Class III2017-04-19

    Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.

  • recall — Class III2017-04-19

    Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.

  • recall — Class III2017-04-19

    Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.

  • recall — Class III2016-12-21

    Labeling: Incorrect or Missing Lot and/or Exp Date: incorrect expiration date of 02/0218 is printed on the container label instead of the correct expiration date of 02/2018.

  • 4832015-08-07

    Complete test data included in records

  • 4832015-08-07

    Returned drug procedures in writing and followed

  • 4832015-08-07

    Scientifically sound laboratory controls

  • 4832015-08-07

    SOPs not followed / documented

  • 4832015-08-07

    Cleaning / Sanitizing / Maintenance

  • 4832015-08-07

    Training , Education , Experience overall

  • 4832015-08-07

    Rejected Material Area

  • recall — Class II2014-08-06

    Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.

  • recall — Class II2013-05-08

    cGMP Deviations: Oral products were not manufactured in accordance with Good Manufacturing Practices.

  • 4832011-03-23

    Written program not followed

  • 4832011-03-23

    Investigations of discrepancies, failures

  • 4832011-03-23

    Failing drug products not rejected

For suppliers

Is this Jubilant Cadista Pharmaceuticals?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.